Ravi Majeti MD, PhD

Ravi Majeti MD, PhD

Hematologist


Director, Stanford Institute for Stem Cell Biology and Regenerative Medicine, Virginia and D. K. Ludwig Professor and Professor of Medicine (Hematology)

View Professional Summary »


Biography


Ravi Majeti MD, PhD is Professor of Medicine, Division of Hematology, and Director of the Institute for Stem Cell Biology and Regenerative Medicine at the Stanford University School of Medicine. He was an undergraduate at Harvard, earned his MD and PhD from UCSF, and trained in Internal Medicine at Brigham and Women’s Hospital in Boston. Dr. Majeti completed his Hematology Fellowship at Stanford, and is a board-certified hematologist. While at Stanford, he completed post-doctoral training in the laboratory of Irving Weissman, where he investigated acute myeloid leukemia (AML) stem cells and therapeutic targeting with anti-CD47 antibodies. With Dr. Weissman, he developed a humanized anti-CD47 antibody, initiated first-in-human clinical trials. Dr. Majeti directs an active NIH-funded laboratory that focuses on the molecular characterization and therapeutic targeting of leukemia stem cells in human hematologic disorders, particularly AML, and has published >100 peer-reviewed articles. He is a recipient of the Burroughs Wellcome Career Award for Medical Scientists, the New York Stem Cell Foundation Robertson Investigator Award, and the Leukemia and Lymphoma Society Scholar Award. Dr. Majeti is currently a member of the Committee on Scientific Affairs for the American Society of Hematology (ASH) and serves of the editorial board of Blood and eLife.

Professional Summary


Education & Certifications
  • Board Certification: American Board of Internal Medicine, Hematology (2007)
  • Medical Education: University of California at San Francisco School of Medicine (2002) CA
  • Residency: Brigham and Women's Hospital Harvard Medical School (2004) MA
  • Fellowship: Stanford University Medical Center (2008) CA

Honors & Awards
  • Career Award for Medical Scientists, Burroughs Wellcome Fund (2008)
  • Robertson Investigator Award, New York Stem Cell Foundation (2011)
  • Scholar Award, Leukemia and Lymphoma Society (2015)

Memberships
  • Member, American Society of Hematology - Committee on Myeloid Neoplasia (2013 - Present)

Administrative Appointments
  • Associate Director, Stanford Ludwig Center for Cancer Stem Cell Research (2014 - Present)
  • Chief, Division of Hematology (2017 - 2022)
  • Co-Director, Translational Research Program - Internal Medicine Residency (2013 - 2017)
  • Co-Director, Hematologic Malignancies Program - Stanford Cancer Institute (2014 - Present)
  • Director, Stanford Institute for Stem Cell Biology and Regenerative Medicine (2022 - Present)

Publications

Practice Locations


SHC- Hematology Palo Alto, CA
Palo Alto, CA

875 Blake Wilbur Dr

Palo Alto , CA 94304

(650) 498-6000

More Clinic Information »

Referring Physicians

LOG INTO MEDLINK